-
Je něco špatně v tomto záznamu ?
Liquid Chromatography-Tandem Mass Spectrometry Method for Determination of Homocysteine in Rat Plasma: Application to the Study of a Rat Model for Tauopathies
A. Kovac, K. Svihlova, A. Michalicova, M. Novak,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
25466230
DOI
10.1093/chromsci/bmu156
Knihovny.cz E-zdroje
- MeSH
- chromatografie kapalinová metody MeSH
- homocystein krev MeSH
- krysa rodu rattus MeSH
- limita detekce MeSH
- lineární modely MeSH
- potkani inbrední SHR MeSH
- potkani transgenní MeSH
- potkani Wistar MeSH
- reprodukovatelnost výsledků MeSH
- stabilita léku MeSH
- studie případů a kontrol MeSH
- tandemová hmotnostní spektrometrie metody MeSH
- tauopatie krev MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Hyperhomocysteinemia is a common occurrence in many neurodegenerative diseases, including tauopathies. We developed and validated a simple and sensitive liquid chromatography-tandem mass spectrometry method for the analysis of homocysteine (Hcy) in rat plasma. Hcy was analyzed using ultra-performance liquid chromatography on a C8 column with detection by positive ESI tandem mass spectrometry. For optimal retention and separation, we used ion-pair reagent-heptafluorobutyric acid. The method utilizes heavy labeled internal standard and does not require any derivatization or extraction step. The procedure was validated in compliance with the European Medicines Agency guideline. The limit of detection was 0.15 µmol/L and the limit of quantification was 0.5 µmol/L. The method showed excellent linearity with regression coefficients higher than 0.99. The accuracy was in the range of 93-98%. The inter-day precision (n = 5 days), expressed as % relative standard deviation, was in the range 3-8%. Using this method, we analyzed plasma samples from two transgenic lines of the rat model for tauopathies.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16010678
- 003
- CZ-PrNML
- 005
- 20160415094749.0
- 007
- ta
- 008
- 160408s2015 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/chromsci/bmu156 $2 doi
- 024 7_
- $a 10.1093/chromsci/bmu156 $2 doi
- 035 __
- $a (PubMed)25466230
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kovac, Andrej $u Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9, Bratislava 84510, Slovak Republic AXON Neuroscience SE, Dvorakovo nabrezie 10, Bratislava 81102, Slovak Republic andrej.kovac@savba.sk.
- 245 10
- $a Liquid Chromatography-Tandem Mass Spectrometry Method for Determination of Homocysteine in Rat Plasma: Application to the Study of a Rat Model for Tauopathies / $c A. Kovac, K. Svihlova, A. Michalicova, M. Novak,
- 520 9_
- $a Hyperhomocysteinemia is a common occurrence in many neurodegenerative diseases, including tauopathies. We developed and validated a simple and sensitive liquid chromatography-tandem mass spectrometry method for the analysis of homocysteine (Hcy) in rat plasma. Hcy was analyzed using ultra-performance liquid chromatography on a C8 column with detection by positive ESI tandem mass spectrometry. For optimal retention and separation, we used ion-pair reagent-heptafluorobutyric acid. The method utilizes heavy labeled internal standard and does not require any derivatization or extraction step. The procedure was validated in compliance with the European Medicines Agency guideline. The limit of detection was 0.15 µmol/L and the limit of quantification was 0.5 µmol/L. The method showed excellent linearity with regression coefficients higher than 0.99. The accuracy was in the range of 93-98%. The inter-day precision (n = 5 days), expressed as % relative standard deviation, was in the range 3-8%. Using this method, we analyzed plasma samples from two transgenic lines of the rat model for tauopathies.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a chromatografie kapalinová $x metody $7 D002853
- 650 _2
- $a stabilita léku $7 D004355
- 650 _2
- $a homocystein $x krev $7 D006710
- 650 _2
- $a limita detekce $7 D057230
- 650 _2
- $a lineární modely $7 D016014
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani inbrední SHR $7 D011918
- 650 _2
- $a potkani transgenní $7 D055647
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 _2
- $a tandemová hmotnostní spektrometrie $x metody $7 D053719
- 650 _2
- $a tauopatie $x krev $7 D024801
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Svihlova, Katarina $u AXON Neuroscience SE, Dvorakovo nabrezie 10, Bratislava 81102, Slovak Republic Department of Chemistry, Faculty of Science, Masaryk University, Kamenice 5/A14, Brno 62500, Czech Republic.
- 700 1_
- $a Michalicova, Alena $u Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9, Bratislava 84510, Slovak Republic AXON Neuroscience SE, Dvorakovo nabrezie 10, Bratislava 81102, Slovak Republic.
- 700 1_
- $a Novak, Michal $u Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9, Bratislava 84510, Slovak Republic AXON Neuroscience SE, Dvorakovo nabrezie 10, Bratislava 81102, Slovak Republic.
- 773 0_
- $w MED00002734 $t Journal of chromatographic science $x 1945-239X $g Roč. 53, č. 6 (2015), s. 953-8
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25466230 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160408 $b ABA008
- 991 __
- $a 20160415094834 $b ABA008
- 999 __
- $a ok $b bmc $g 1114107 $s 935046
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 53 $c 6 $d 953-8 $e 20141202 $i 1945-239X $m Journal of chromatographic science $n J Chromatogr Sci $x MED00002734
- LZP __
- $a Pubmed-20160408